Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy

Int J Cardiol. 2024 May 1:402:131885. doi: 10.1016/j.ijcard.2024.131885. Epub 2024 Feb 20.

Abstract

Cardiac resynchronization therapy (CRT) is a device-based treatment applied to patients with a specific profile of heart failure. According to current guidelines, indication for CRT is given on the basis of QRS morphology and duration, and traditional transthoracic echocardiography is mainly used to estimate left ventricular (LV) ejection fraction. However, the identification of patients who may benefit from CRT remains challenging, since the application of the above-mentioned guidelines is still associated with a high rate of non-responders. The assessment of various aspects of LV mechanics (including contractile synchrony, coordination and propagation, and myocardial work) performed by conventional and novel ultrasound technologies, first of all speckle tracking echocardiography (STE), may provide additional, useful information for CRT patients' selection, in particular among non-LBBB patients, who generally respond less to CRT. A multiparametric approach, based on the combination of ECG criteria and echocardiographic indices of LV dyssynchrony/discoordination would be desirable to improve the prediction of CRT response.

Keywords: Cardiac resynchronization therapy (CRT); Echocardiography; Heart failure (HF); Myocardial work (MW); Speckle tracking echocardiography (STE); Strain.

Publication types

  • Review

MeSH terms

  • Cardiac Resynchronization Therapy*
  • Echocardiography
  • Heart Failure* / diagnostic imaging
  • Heart Failure* / therapy
  • Humans
  • Stroke Volume
  • Treatment Outcome
  • Ventricular Function, Left / physiology